Nencini P, Graziani M, Grassi M C
Institute of Medical Pharmacology, University La Sapienza, Rome, Italy.
Drug Alcohol Depend. 1988 Oct;22(1-2):9-14. doi: 10.1016/0376-8716(88)90031-2.
The aim of the present study was to evaluate the ability of the calcium channel blocker (CCE), nimodipine (NIM), to interact with (+/-)-amphetamine (AMPH) in modifying ingestive behavior. Rats performed in a water-reinforced runway paradigm with multiple trials. Water was available in sufficient quantity to produce satiety under control conditions as measured by a decline in response rate over the session. NIM and AMPH, given alone, did not produce significant effects on performance but produced behavioral changes when administered in combination. In particular, the combination of the highest doses (13 mg/kg i.p. NIM plus 0.56 mg/kg i.p. AMPH) initially depressed both running and drinking, whereas in later trials it increased running rate, without producing a parallel increase in water intake. These results suggest that NIM enhances AMPH-produced inhibition of drinking, whereas it first depresses and then enhances the AMPH-mediated runway performance, suggesting the rate dependency of this latter effect.
本研究的目的是评估钙通道阻滞剂(CCE)尼莫地平(NIM)与(±)-苯丙胺(AMPH)相互作用对摄食行为的影响。大鼠在水强化跑道范式下进行多次试验。在对照条件下,有足够的水可产生饱腹感,这通过整个实验过程中反应率的下降来衡量。单独给予NIM和AMPH对行为表现没有显著影响,但联合给药时会产生行为变化。特别是,最高剂量组合(腹腔注射13mg/kg NIM加腹腔注射0.56mg/kg AMPH)最初会抑制奔跑和饮水,而在后续试验中会提高奔跑速度,且饮水并未相应增加。这些结果表明,NIM增强了AMPH对饮水的抑制作用,而它首先抑制然后增强了AMPH介导的跑道行为表现,提示后一种效应具有速率依赖性。